0000950170-24-072420.txt : 20240612
0000950170-24-072420.hdr.sgml : 20240612
20240612160508
ACCESSION NUMBER: 0000950170-24-072420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240610
FILED AS OF DATE: 20240612
DATE AS OF CHANGE: 20240612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Feller Faye
CENTRAL INDEX KEY: 0001937361
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20859
FILM NUMBER: 241038397
MAIL ADDRESS:
STREET 1: 919 EAST HILLSDALE BOULEVARD
STREET 2: SUITE 250
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GERON CORP
CENTRAL INDEX KEY: 0000886744
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 752287752
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 919 EAST HILLSDALE BOULEVARD
STREET 2: SUITE 250
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6504737700
MAIL ADDRESS:
STREET 1: 919 EAST HILLSDALE BOULEVARD
STREET 2: SUITE 250
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: GERON CORPORATION
DATE OF NAME CHANGE: 19960521
4
1
ownership.xml
4
X0508
4
2024-06-10
0000886744
GERON CORP
GERN
0001937361
Feller Faye
C/O GERON CORPORATION
919 E HILLSDALE BLVD. SUITE 250
FOSTER CITY
CA
94404
false
true
false
false
EVP, Chief Medical Officer
false
Common Stock
2024-06-10
4
M
false
112500
1.060
A
112500
D
Common Stock
2024-06-10
4
M
false
20000
1.060
A
20000
D
Common Stock
2024-06-10
4
M
false
155400
1.295
A
155400
D
Common Stock
2024-06-10
4
S
false
287900
4.634
D
0
D
Stock Option (right to buy)
1.060
2024-06-10
4
M
false
112500
0
D
2032-02-15
Common Stock
112500
87500
D
Stock Option (right to buy)
1.060
2024-06-10
4
M
false
20000
0
D
2032-02-15
Common Stock
20000
0
D
Stock Option (right to buy)
1.295
2024-06-10
4
M
false
155400
0
D
2030-02-11
Common Stock
155400
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
This option vests in a series of 48 consecutive equal monthly installments commencing February 16, 2022 (of which 112,500 shares were vested as of the exercise date), provided the optionee continues to provide services to the Company.
Option fully vested.
/s/ Scott A. Samuels for Faye Feller
2024-06-12